COMMUNIQUÉS West-GlobeNewswire

-
Loxo Oncology Announces LOXO-292 Durability Update in Patients with RET-Mutant Medullary Thyroid Cancer and RET Fusion-Positive Thyroid Cancer from LIBRETTO-001 at the 88th Annual Meeting of the American Thyroid Association
06/10/2018 -
New SPINRAZA® (nusinersen) Data Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy
06/10/2018 -
Akcea et Ionis annoncent l’homologation de TEGSEDIMC (inotersen pour injection) au Canada
06/10/2018 -
Adamas Announces New Employment Inducement Grant
05/10/2018 -
Akcea Announces Its Access and Distribution Strategy for TEGSEDI™ (inotersen)
05/10/2018 -
Akcea and Ionis Receive FDA Approval of TEGSEDI™ (inotersen) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
05/10/2018 -
Cogentix Medical, Inc. / Laborie Medical Technologies Canada ULC Merger Litigation
05/10/2018 -
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/10/2018 -
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/10/2018 -
Solid Biosciences to Present at the Chardan Genetic Medicines Conference
05/10/2018 -
Retrophin to Present Long-Term Data from Phase 2 DUET Study of Sparsentan in FSGS at ASN Kidney Week 2018
05/10/2018 -
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/10/2018 -
Genetic Testing: Thinking About An At-Home Test for Alzheimer’s Risk Gene?
05/10/2018 -
Sienna Announces Third Quarter 2018 Results Release Date and Conference Call
05/10/2018 -
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs, Raising Gross Proceeds of $345 Million and Full Exercise of Underwriters' Option to Purchase Additional ADSs
05/10/2018 -
Co-administration of AAV Vectors with SVP-Rapamycin Enables Vector Re-administration in Pre-clinical Gene Therapy Study Published in Nature Communications by Généthon and Selecta Biosciences
05/10/2018 -
About acquisition of significant shareholding
05/10/2018 -
XBiotech annonce la conclusion du recrutement pour l'étude multicentrique de phase 2 d'évaluation de Bermekimab chez les patients atteints d'une dermatite atopique
05/10/2018 -
KemPharm Announces Pricing of Public Offering of Common Stock
05/10/2018
Pages